Organogenesis Holdings (ORGO) Non Operating Income (2017 - 2026)

Organogenesis Holdings' Non Operating Income history runs 10 years deep, the most recent figure standing at $38000.0 for Q1 2026.

• In Q1 2026, Non Operating Income fell 96.05% year-over-year to $38000.0; the TTM figure through Mar 2026 stood at $3.4 million (up 62.18% YoY), while the FY2025 annual figure was $2.3 million, up 11280.0% from the prior year.
• Non Operating Income was $38000.0 for Q1 2026 at Organogenesis Holdings, down from $2.2 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $2.2 million in Q4 2025 to a low of -$751000.0 in Q2 2022.
• Historically, Non Operating Income has averaged $301235.3 across 5 years, with a median of $23000.0 in 2024.
• The sharpest annual moves came in 2023 and 2025: Non Operating Income sank 20766.67% in 2023, then jumped 4086.96% in 2025.
• A 5-year view of Non Operating Income shows it stood at $2.0 million in 2022, then plunged by 125.77% to -$527000.0 in 2023, then surged by 399.43% to $1.6 million in 2024, then soared by 38.34% to $2.2 million in 2025, then plunged by 98.26% to $38000.0 in 2026.
• The last three Non Operating Income figures came in at $38000.0 (Q1 2026), $2.2 million (Q4 2025), and $433000.0 (Q3 2025), per Business Quant data.